Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Adenovirus vectored vaccines are a highly effective strategy to induce cellular immune responses which are particularly effective against intracellular pathogens. Recombinant simian adenovirus vectors were developed to circumvent the limitations imposed by the use of human adenoviruses due to widesp...

Podrobná bibliografie
Hlavní autoři:	Folegatti, P, Bellamy, D, Roberts, R, Powlson, J, Edwards, N, Mair, C, Bowyer, G, Poulton, I, Mitton, C, Green, N, Berrie, E, Lawrie, A, Hill, A, Ewer, K, Hermon-Taylor, J, Gilbert, S
Médium:	Journal article
Vydáno:	MDPI 2019

Podobné jednotky

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Autor: Pedro M. Folegatti, a další
Vydáno: (2019-05-01)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Autor: Zhang, C, a další
Vydáno: (2023)

CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination
Autor: Sharpe, HR, a další
Vydáno: (2022)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Autor: Cheng Zhang, a další
Vydáno: (2023-06-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
Autor: Adam Berg, a další
Vydáno: (2021-10-01)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
Autor: Hannah R. Sharpe, a další
Vydáno: (2022-03-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
Autor: Antrobus, R, a další
Vydáno: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
Autor: Antrobus, R, a další
Vydáno: (2014)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
Autor: Jinnam Kim, a další
Vydáno: (2023-04-01)

Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
Autor: Moreira Folegatti, P
Vydáno: (2021)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
Autor: O'Hara, G, a další
Vydáno: (2012)

A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial
Autor: Folegatti, P, a další
Vydáno: (2021)

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa
Autor: Ashley C. Beavis, a další
Vydáno: (2023-07-01)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
Autor: Folegatti, P, a další
Vydáno: (2021)

Safety and immunogenicity of ChAdOx1 MERS Vaccine Candidate in Healthy Middle Eastern Adults: a dose-escalation, open-label, non-randomised, phase 1b trial
Autor: Bosaeed, M, a další
Vydáno: (2021)

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
Autor: Charlotte Davis, a další
Vydáno: (2024-06-01)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
Autor: Dicks, M, a další
Vydáno: (2015)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
Autor: Edmund G.-T. Wee, a další
Vydáno: (2024-08-01)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Autor: Pedro M. Folegatti, a další
Vydáno: (2021-03-01)

Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels
Autor: Alharbi, N, a další
Vydáno: (2019)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
Autor: Jer-Hwa Chang, a další
Vydáno: (2022-02-01)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Autor: Hermosilla, E, a další
Vydáno: (2022)

Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
Autor: Folegatti, PM, a další
Vydáno: (2019)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
Autor: Ting-Yun Lin, a další
Vydáno: (2022-08-01)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
Autor: Tamsin Cargill, a další
Vydáno: (2023-11-01)

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
Autor: Nawamin Pinpathomrat, a další
Vydáno: (2022-05-01)

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
Autor: Ogbe, A, a další
Vydáno: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Autor: Eduardo Hermosilla, a další
Vydáno: (2022-03-01)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
Autor: López-Camacho, C, a další
Vydáno: (2020)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
Autor: César López-Camacho, a další
Vydáno: (2020-06-01)

Is the ChAdOx1 Vaccine Safe and Immunogenic as Prophylactic Measure Against the Lethal Human-Coronaviruses? A Systematic Review
Autor: Andréia Michelle Alves Cunha de Alcântar, a další
Vydáno: (2023-07-01)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Autor: Ane Ogbe, a další
Vydáno: (2022-04-01)

Simian adenoviruses as vaccine vectors
Autor: Morris, S, a další
Vydáno: (2016)

Simian adenoviruses as vaccine vectors
Autor: Morris, S, a další
Vydáno: (2016)

Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand
Autor: Kriangkrai Chawansuntati, a další
Vydáno: (2024-06-01)

Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses
Autor: Alex Olvera, a další
Vydáno: (2024-03-01)

Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
Autor: Nawamin Pinpathomrat, a další
Vydáno: (2022-09-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
Autor: Folegatti, P, a další
Vydáno: (2019)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Autor: Folegatti, PM, a další
Vydáno: (2020)

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Autor: Barrett, J, a další
Vydáno: (2020)